Prosight Management, LP

Holdings History for Janux Therapeutics, Inc. - Common Stock (JANX)

Symbol: JANX on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Shares Owned: 3,157,220 shares
Security Ownership %: 5.3%

Shares, Excluding Options vs Price

Value, Excluding Options

W. Lawrence Hawkins ownership in Janux Therapeutics, Inc. Common Stock (JANX)

06 Feb 2026 - W. Lawrence Hawkins has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,157,220 shares of Janux Therapeutics, Inc. Common Stock (JANX). This represents 5.3% ownership of the company. This is the first filing by Prosight Management, LP disclosing ownership of Janux Therapeutics, Inc. Common Stock (JANX).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
W. Lawrence Hawkins	5.3%		$43,569,636	3,157,220			$13.80	13G	03 Feb 2026	06 Feb 2026, 16:23

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	6.8%	+4.4%	$33,016,817	2,392,523	+1,527,173	+176%	$13.80	Q4 2025
30 Sep 2025	5.1%	+0.07%	$21,149,154	865,350	+11,446	+1.3%	$24.44	Q3 2025
30 Jun 2025	4.8%	+0.92%	$19,725,182	853,904	+164,003	+24%	$23.10	Q2 2025
31 Mar 2025	6.1%	+3.2%	$18,627,327	689,901	+360,133	+100%	$27.00	Q1 2025
31 Dec 2024	4.9%	+1.9%	$17,655,779	329,768	+124,768	+61%	$53.54	Q4 2024
30 Sep 2024	2.4%	+2.4%	$9,313,150	205,000	+205,000	NEW	$45.43	Q3 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.